-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Compass Therapeutics, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q1 2018 to Q2 2025.
- Compass Therapeutics, Inc. General and Administrative Expense for the quarter ending June 30, 2025 was $4.65M, a 1.48% decline year-over-year.
- Compass Therapeutics, Inc. General and Administrative Expense for the twelve months ending June 30, 2025 was $16.7M, a 19.3% increase year-over-year.
- Compass Therapeutics, Inc. annual General and Administrative Expense for 2024 was $15.1M, a 23.6% increase from 2023.
- Compass Therapeutics, Inc. annual General and Administrative Expense for 2023 was $12.2M, a 5.02% increase from 2022.
- Compass Therapeutics, Inc. annual General and Administrative Expense for 2022 was $11.7M, a 6.69% increase from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)